Insider · CIK 0001705824
Matthew Paul Kowalsky
Files at ENTA (ENANTA PHARMACEUTICALS INC). First filing -, latest -.
Matthew Paul Kowalsky files SEC Form 4 as officer at ENTA (ENANTA PHARMACEUTICALS INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Matthew Paul Kowalsky has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | AGrant or award Common Stock | +1,318 | $0.00 | $0 | 1,318 | Feb 13, 2026 |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | AGrant or award Common Stock | +4,175 | $0.00 | $0 | 5,493 | Feb 13, 2026 |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | FTax withholding Common Stock | -1,902 | $14.25 | $27k | 3,591 | Feb 13, 2026 |
| Nov 25, 2025 | ENTA ENANTA PHARMACEUTICALS INC | AGrant or award Stock Option (right to buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Nov 26, 2025 |
| Nov 27, 2024 | ENTA ENANTA PHARMACEUTICALS INC | AGrant or award Stock Option (right to buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Nov 27, 2024 |
Questions about Matthew Paul Kowalsky
Answered from the filings on this page, as of the latest one.
Is Matthew Paul Kowalsky buying or selling?
Matthew Paul Kowalsky has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Matthew Paul Kowalsky's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Paul Kowalsky has 0.
Where does Matthew Paul Kowalsky file Form 4?
Matthew Paul Kowalsky has filed Form 4 at ENTA (ENANTA PHARMACEUTICALS INC) as Chief Legal Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.